{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T11:00:17Z","timestamp":1648897217485},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1157\/13076646","type":"journal-article","created":{"date-parts":[[2005,7,11]],"date-time":"2005-07-11T10:11:02Z","timestamp":1121076662000},"page":"255-275","source":"Crossref","is-referenced-by-count":8,"title":["Imagen de neurotransmisi\u00f3n dopamin\u00e9rgica en los s\u00edndromes parkinsonianos"],"prefix":"10.1016","volume":"24","author":[{"given":"D.","family":"Garc\u00eda Sol\u00eds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13076646_bib1","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","article-title":"Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease","volume":"57","author":"Hughes","year":"2001","journal-title":"Neurology"},{"key":"10.1157\/13076646_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S0317167100031814","article-title":"Accuracy of clinical diagnosis in parkinsonism-a prospective study","volume":"18","author":"Rajput","year":"1991","journal-title":"Can J Neurol Sci"},{"key":"10.1157\/13076646_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiophatic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1157\/13076646_bib4","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1157\/13076646_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00259-004-1733-4","article-title":"Early-stage [123I]\u03b2 -CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease","volume":"32","author":"Stoffers","year":"2005","journal-title":"Eur J Nucl Med"},{"key":"10.1157\/13076646_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/305137a0","article-title":"Dopamine visualized in the basal ganglia of living man","volume":"305","author":"Garnett","year":"1983","journal-title":"Nature"},{"key":"10.1157\/13076646_bib7","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1523\/JNEUROSCI.15-03-01714.1995","article-title":"The dopamine transporter: Immunochemical characterization and localization in brain","volume":"15","author":"Ciliax","year":"1995","journal-title":"J Neurosci"},{"key":"10.1157\/13076646_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/(SICI)1096-9861(19971117)388:2<211::AID-CNE3>3.0.CO;2-4","article-title":"Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra","volume":"388","author":"Hersch","year":"1997","journal-title":"J Comp Neurol"},{"key":"10.1157\/13076646_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/syn.890130402","article-title":"SPECT imaging of dopamine and serotonin transporters with [123I]\u03b2 -CIT: pharmacological characterization of brain uptake in nonhuman primates","volume":"13","author":"Laruelle","year":"1993","journal-title":"Synapse"},{"key":"10.1157\/13076646_bib10","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/jcbfm.1994.131","article-title":"Graphical, kinetic, and equilibrium analyses of in vivo [I123]beta-CIT binding to dopamine transporter in healthy human subjects","volume":"14","author":"Laruelle","year":"1994","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1157\/13076646_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s002590050190","article-title":"Human biodistribution and dosimetry of I 123-FP-CIT: a potent radioligand for imaging of dopamine transporters","volume":"25","author":"Booij","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1157\/13076646_bib12","first-page":"1760","article-title":"Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP\/SPECT and fluorine-18-FDOPA\/ PET","volume":"37","author":"Ishikawa","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1157\/13076646_bib13","first-page":"584","article-title":"Binding of [99mTc]Trodat-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers","volume":"41","author":"Mozley","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1157\/13076646_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00259-003-1331-x","article-title":"Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson's disease","volume":"31","author":"Huang","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1157\/13076646_bib15","first-page":"49","article-title":"99mTc-TRODAT-1 imaging of multiple system atrophy","volume":"45","author":"Lu","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1157\/13076646_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0014-2999(95)00594-3","article-title":"The vesicular monoamine transporter is not regulated by dopaminergic drug treatments","volume":"294","author":"Vander Borght","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1157\/13076646_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/jnnp.59.6.597","article-title":"Clinical and [18F] dopa PET findings in early Parkinson's disease","volume":"59","author":"Morrish","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1157\/13076646_bib18","first-page":"1","article-title":"Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease","volume":"38","author":"Asenbaum S Brucke","year":"1997","journal-title":"Nucl Med"},{"key":"10.1157\/13076646_bib19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1212\/WNL.46.1.231","article-title":"[123I] beta-CIT\/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease","volume":"46","author":"Marek","year":"1996","journal-title":"Neurology"},{"key":"10.1157\/13076646_bib20","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1212\/WNL.55.10.1540","article-title":"A multicenter assessment of dopamine transporter imaging with dopascan\/SPECT in parkinsonism","volume":"55","year":"2000","journal-title":"Neurology"},{"key":"10.1157\/13076646_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","article-title":"In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease","volume":"47","author":"Lee","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1157\/13076646_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/(SICI)1098-2396(19990301)31:3<178::AID-SYN2>3.0.CO;2-M","article-title":"Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models","volume":"31","author":"Ito","year":"1999","journal-title":"Synapse"},{"key":"10.1157\/13076646_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","volume":"54","author":"Whone","year":"2003","journal-title":"Ann Neurol"},{"issue":"Suppl 1A","key":"10.1157\/13076646_bib24","first-page":"80","article-title":"Does levodopa slow or hasten the rate of progression of Parkinson's disease? The results of the ELLDOPA trial","volume":"60","year":"2003","journal-title":"Neurology"},{"key":"10.1157\/13076646_bib25","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.287.13.1653","article-title":"Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progresi\u00f3n","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"10.1157\/13076646_bib26","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.1990.00530120034007","article-title":"The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease","volume":"47","author":"Leenders","year":"1990","journal-title":"Arch Neurol"},{"key":"10.1157\/13076646_bib27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","article-title":"Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov Disord"},{"key":"10.1157\/13076646_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.1265","article-title":"Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study","volume":"17","author":"Pirker","year":"2002","journal-title":"Mov Disord"},{"issue":"Suppl 7","key":"10.1157\/13076646_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/mds.10579","article-title":"Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?","volume":"18","author":"Pirker","year":"2003","journal-title":"Mov Disord"},{"key":"10.1157\/13076646_bib30","first-page":"1112","article-title":"Iodine-123-iodobenzamide binding in parkinsonism: reduction by dopamine agonist but not L-dopa","volume":"37","author":"Schwarz","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1157\/13076646_bib31","first-page":"2076","article-title":"Estimation of dopamine D2-receptor binding potential in the striatum with iodine -123-IBZM SPECT: technical and interobserver variability","volume":"34","author":"Verhoeff","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1157\/13076646_bib32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.42.3.556","article-title":"123I-iodobenzamide SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism","volume":"42","author":"Schwarz","year":"1992","journal-title":"Neurology"},{"key":"10.1157\/13076646_bib33","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/mds.870120610","article-title":"123I-IBZM binding predicts dopamine responsiveness in patients with parkinsonism and previous dopaminomimetic therapy","volume":"12","author":"Schwarz","year":"1997","journal-title":"Mov Disord"},{"key":"10.1157\/13076646_bib34","first-page":"473","article-title":"Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications","volume":"175","author":"Frankle","year":"2004","journal-title":"Psycopharmacology"},{"key":"10.1157\/13076646_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/1098-2396(200102)39:2<101::AID-SYN1>3.0.CO;2-1","article-title":"Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease","volume":"39","author":"Booij","year":"2001","journal-title":"Synapse"},{"key":"10.1157\/13076646_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002590000460","article-title":"The clinical benefit of imaging striatal dopamine transporters with [123I]FPCIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism","volume":"28","author":"Booij","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1157\/13076646_bib37","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mds.10482","article-title":"Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3-months observations","volume":"18","author":"Benamer","year":"2003","journal-title":"Mov Disord"},{"key":"10.1157\/13076646_bib38","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00259-002-0938-7","article-title":"Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand","volume":"29","author":"Lokkegaard","year":"2002","journal-title":"Eur J Nucl Med"},{"key":"10.1157\/13076646_bib39","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/mds.20112","article-title":"Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes","volume":"19","author":"Catafau","year":"2004","journal-title":"Mov Disord"},{"key":"10.1157\/13076646_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mds.870131310","article-title":"Epidemiology and genetics of essential tremor","volume":"13","author":"Brin","year":"1998","journal-title":"Mov Disord"},{"issue":"Suppl 7","key":"10.1157\/13076646_bib41","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1002\/mds.10574","article-title":"Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders","volume":"18","author":"Marshall","year":"2003","journal-title":"Mov Disord"},{"key":"10.1157\/13076646_bib42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov Disord"},{"key":"10.1157\/13076646_bib43","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/brain\/117.4.859","article-title":"The behavioural and motor consequences of focal lesions of the basal ganglia","volume":"117","author":"Bhatia","year":"1994","journal-title":"Brain"},{"key":"10.1157\/13076646_bib44","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00702-004-0192-1","article-title":"Parkinsonism following striatal infarcts: incidence in a prospective stroke unit cohort","volume":"111","author":"Peralta","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1157\/13076646_bib45","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.10092","article-title":"[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease","volume":"17","author":"Gerschlager","year":"2002","journal-title":"Mov Disord"},{"key":"10.1157\/13076646_bib46","first-page":"408","article-title":"Differential diagnosis of Parkinson's disease and vascular parkinsonism by 99mTc-TRODAT-1","volume":"42","author":"Tzen","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1157\/13076646_bib47","first-page":"1688","article-title":"123I-FP-CIT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism","volume":"45","author":"Lorberboym","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1157\/13076646_bib48","first-page":"131","article-title":"Confirming Parkinson's disease with 123I-FP-CIT SPECT","volume":"6","author":"O'Sullivan","year":"1999","journal-title":"Eur J Neurology"},{"key":"10.1157\/13076646_bib49","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00415-002-0776-3","article-title":"Normal dopamine transporter binding en dopa responsive distonia","volume":"249","author":"Huang","year":"2002","journal-title":"J Neurol"},{"key":"10.1157\/13076646_bib50","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1212\/WNL.56.2.266","article-title":"SPECT imaging of the dopamine transporter in juvenile-onset distonia","volume":"56","author":"O'Sullivan","year":"2001","journal-title":"Neurology"},{"key":"10.1157\/13076646_bib51","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1212\/01.WNL.0000037484.28297.66","article-title":"[123-I]FP-CIT SPECT in the early diagnosis of PD presenting as exercise-induced distonia","volume":"59","author":"Katzenschlager","year":"2002","journal-title":"Neurology"},{"key":"10.1157\/13076646_bib52","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archinte.156.5.487","article-title":"Lewy body disease and dementia. A review","volume":"156","author":"Kalra","year":"1996","journal-title":"Arch Int Med"},{"key":"10.1157\/13076646_bib53","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.162.3.385","article-title":"The Lewy body variant of Alzheimer's disease: clinical and pathological findings","volume":"162","author":"Forstl","year":"1993","journal-title":"Br J Psychiatry"},{"key":"10.1157\/13076646_bib54","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/brain\/122.8.1449","article-title":"Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's disease: rostro-caudal distribution","volume":"122","author":"Piggott","year":"1999","journal-title":"Brain"},{"key":"10.1157\/13076646_bib55","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archneur.61.6.919","article-title":"Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies","volume":"61","author":"O\u2019Brian","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1157\/13076646_bib56","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/jnnp.73.2.134","article-title":"Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand","volume":"73","author":"Walker","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1157\/13076646_bib57","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB internacional workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1157\/13076646_bib58","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/01.WNL.0000123248.39847.1D","article-title":"Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease","volume":"62","author":"Walker","year":"2004","journal-title":"Neurology"},{"issue":"Suppl 7","key":"10.1157\/13076646_bib59","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/mds.10576","article-title":"Dementia with Lewy bodies versus Alzheimer's disease: role of dopamine transporter imaging","volume":"18","author":"Costa","year":"2003","journal-title":"Mov Disord"},{"key":"10.1157\/13076646_bib60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mds.10042","article-title":"Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP","volume":"17","author":"Kim","year":"2002","journal-title":"Mov Disord"},{"key":"10.1157\/13076646_bib61","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10072-003-0103-5","article-title":"123I-Ioflupane\/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson\u2019disease, multiple system atrophy, and progressive supranuclear palsy","volume":"24","author":"Antonini","year":"2003","journal-title":"Neurol Sci"},{"key":"10.1157\/13076646_bib62","first-page":"4851","article-title":"Voxel-wise analysis of [123I]\u03b2 -CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiophatic Parkinson's disease","volume":"0","author":"Scherfler","year":"2005","journal-title":"Brain"},{"key":"10.1157\/13076646_bib63","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0","article-title":"[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy and corticobasal degeneration","volume":"15","author":"Pirker","year":"2000","journal-title":"Mov Disord"},{"key":"10.1157\/13076646_bib64","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.410310209","article-title":"Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography","volume":"31","author":"Brooks","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1157\/13076646_bib65","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/brain\/120.12.2187","article-title":"Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease","volume":"120","author":"Antonini","year":"1997","journal-title":"Brain"},{"key":"10.1157\/13076646_bib66","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mds.870130107","article-title":"123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism","volume":"13","author":"Schwarz","year":"1998","journal-title":"Mov Disord"},{"key":"10.1157\/13076646_bib67","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/jnnp.57.9.1047","article-title":"Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IIBZM-SPECT","volume":"57","author":"Schulz","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1157\/13076646_bib68","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/mds.10106","article-title":"Steele-Richardson-Olszewski s\u00edndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: 123I-IBZM-SPECT and MRI study","volume":"17","author":"Arnold","year":"2002","journal-title":"Mov Disord"},{"key":"10.1157\/13076646_bib69","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jnnp.73.5.517","article-title":"Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multitracer PET imaging","volume":"73","author":"Ghaemi","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1157\/13076646_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0720-048X(03)00214-6","article-title":"Differential metabolic pattern analysis of Parkinsonism on the 18F-FDG-PET","volume":"51","author":"Juh","year":"2004","journal-title":"Eur J Radiol"},{"key":"10.1157\/13076646_bib71","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00006231-200107000-00007","article-title":"Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET","volume":"22","author":"Zhang","year":"2001","journal-title":"Nucl Med Com"},{"key":"10.1157\/13076646_bib72","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/jnnp.64.3.314","article-title":"Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET","volume":"64","author":"Morrish","year":"1998","journal-title":"Neurol Neurosurg Psychiatry"},{"key":"10.1157\/13076646_bib73","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1212\/WNL.57.11.2089","article-title":"[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression","volume":"57","author":"Marek","year":"2001","journal-title":"Neurology"},{"key":"10.1157\/13076646_bib74","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jnnp.74.3.294","article-title":"[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease","volume":"74","author":"Winogrodzka","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1157\/13076646_bib75","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/1531-8249(200006)47:6<804::AID-ANA14>3.0.CO;2-F","article-title":"Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT","volume":"47","author":"Nurmi","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1157\/13076646_bib76","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/syn.10192","article-title":"Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET","volume":"48","author":"Nurmi","year":"2003","journal-title":"Synapse"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698205751739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698205751739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:20:39Z","timestamp":1551831639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212698205751739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0212698205751739"],"URL":"https:\/\/doi.org\/10.1157\/13076646","relation":{},"ISSN":["0212-6982"],"issn-type":[{"value":"0212-6982","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}